advanceCOR

About:

advanceCOR is a clinical drug developing company that focuses on therapeutics and diagnostics for heart and vascular diseases.

Website: http://www.advancecor.de/

Top Investors: KfW, Bayern Kapital, HTGF | High-Tech Gruenderfonds, MIG Capital, OCCIDENT

Description:

advanceCOR is a clinical drug developing company that focuses on therapeutics and diagnostics for heart and vascular diseases. Its products include Revacept, a human Fc fusion protein, which prevents the local activation of platelets at sites of vascular injury; COR-2, a recombinant protein that interferes with the generation of foam cells; and COR-3, a recombinant protein, which specifically binds to atherosclerotic plaques, and then bi-specifically binds to circulating progenitor cells to trap the endogenously occurring progenitor cells for accelerated plaque healing.